1. Home
  2. SG vs EMBC Comparison

SG vs EMBC Comparison

Compare SG & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sweetgreen Inc.

SG

Sweetgreen Inc.

HOLD

Current Price

$6.12

Market Cap

640.3M

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.77

Market Cap

525.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SG
EMBC
Founded
2007
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
525.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SG
EMBC
Price
$6.12
$8.77
Analyst Decision
Hold
Buy
Analyst Count
15
2
Target Price
$8.43
$18.50
AVG Volume (30 Days)
3.6M
797.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
6.78%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
$679,474,000.00
N/A
Revenue This Year
$7.64
$1.17
Revenue Next Year
$8.29
N/A
P/E Ratio
N/A
$11.96
Revenue Growth
0.39
N/A
52 Week Low
$4.49
$8.47
52 Week High
$21.67
$15.55

Technical Indicators

Market Signals
Indicator
SG
EMBC
Relative Strength Index (RSI) 60.84 39.62
Support Level $5.10 $8.60
Resistance Level $6.12 $9.36
Average True Range (ATR) 0.35 0.35
MACD 0.11 0.06
Stochastic Oscillator 97.29 40.38

Price Performance

Historical Comparison
SG
EMBC

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Its menu involves, Kids' meal, salads, sides, local items, Protein Plates, Desserts, Drinks and Others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: